158 related articles for article (PubMed ID: 2869851)
21. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin.
Davis MJ; Dawes PT; Beswick E; Lewin IV; Stanworth DR
Br J Rheumatol; 1989 Oct; 28(5):410-3. PubMed ID: 2571386
[TBL] [Abstract][Full Text] [Related]
22. [Therapy of seronegative oligoarthritis with salazopyrine].
Stroehmann I; Wüstenhagen E; Martini M
Z Rheumatol; 1987; 46(2):79-82. PubMed ID: 2885989
[TBL] [Abstract][Full Text] [Related]
23. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
[TBL] [Abstract][Full Text] [Related]
24. Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment?
Savastano M; Marioni G; Bernini G; Punzi L
Acta Otolaryngol; 2005 Jun; 125(6):671-3. PubMed ID: 16076720
[TBL] [Abstract][Full Text] [Related]
25. Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis.
Hendrix S; Koenig A; Li W; Singh A
J Int Med Res; 2013 Oct; 41(5):1606-11. PubMed ID: 23975857
[TBL] [Abstract][Full Text] [Related]
26. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial.
Egsmose C; Hansen TM; Andersen LS; Beier JM; Christensen L; Ejstrup L; Peters ND; van der Heijde DM
Ann Rheum Dis; 1997 Jan; 56(1):32-6. PubMed ID: 9059138
[TBL] [Abstract][Full Text] [Related]
27. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment.
Taylor HG; Beswick EJ; Dawes PT
Clin Rheumatol; 1991 Mar; 10(1):43-8. PubMed ID: 1676621
[TBL] [Abstract][Full Text] [Related]
28. [Sulfasalazine in rheumatology].
Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
[TBL] [Abstract][Full Text] [Related]
29. Repeat ileocolonoscopy in reactive arthritis.
Mielants H; Veys EM; Joos R; Cuvelier C; De Vos M
J Rheumatol; 1987 Jun; 14(3):456-8. PubMed ID: 2887654
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial.
van der Heijde D; Braun J; Dougados M; Sieper J; Pedersen R; Szumski A; Koenig AS
Rheumatology (Oxford); 2012 Oct; 51(10):1894-905. PubMed ID: 22772319
[TBL] [Abstract][Full Text] [Related]
31. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
Mielants H; De Vos M; Cuvelier C; Veys EM
Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
[TBL] [Abstract][Full Text] [Related]
32. Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial.
Nissilä M; Lehtinen K; Leirisalo-Repo M; Luukkainen R; Mutru O; Yli-Kerttula U
Arthritis Rheum; 1988 Sep; 31(9):1111-6. PubMed ID: 2901839
[TBL] [Abstract][Full Text] [Related]
33. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study.
Dougados M; vam der Linden S; Leirisalo-Repo M; Huitfeldt B; Juhlin R; Veys E; Zeidler H; Kvien TK; Olivieri I; Dijkmans B
Arthritis Rheum; 1995 May; 38(5):618-27. PubMed ID: 7748217
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic aspects of spondyloarthropathies -- a review.
Leirisalo-Repo M
Scand J Rheumatol; 1998; 27(5):323-8. PubMed ID: 9808393
[TBL] [Abstract][Full Text] [Related]
35. Ankylosing spondylitis. Current drug treatment.
Gran JT; Husby G
Drugs; 1992 Oct; 44(4):585-603. PubMed ID: 1281074
[TBL] [Abstract][Full Text] [Related]
36. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.
Clegg DO; Reda DJ; Abdellatif M
Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027
[TBL] [Abstract][Full Text] [Related]
37. Sulphasalazine and ankylosing spondylitis: an open pilot study.
Coelho Andrade LE; Atra E; Bosi Ferraz M
Clin Exp Rheumatol; 1989; 7(6):661-2. PubMed ID: 2575477
[No Abstract] [Full Text] [Related]
38. Sulphasalazine-induced aseptic meningitis with facial and nuchal edema in a patient with spondyloarthritis.
Tay SH; Lateef A; Cheung PP
Int J Rheum Dis; 2012 Aug; 15(4):e71-2. PubMed ID: 22898230
[No Abstract] [Full Text] [Related]
39. Side effects of sulphasalazine in patients with rheumatic diseases or inflammatory bowel disease.
Laasila K; Leirisalo-Repo M
Scand J Rheumatol; 1994; 23(6):338-40. PubMed ID: 7801059
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of sulphasalazine in the treatment of spondyloarthropathies.
Dougados M; Maetzel A; Mijiyawa M; Amor B
Ann Rheum Dis; 1992 Aug; 51(8):955-8. PubMed ID: 1358038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
